Skip to main content
Have a personal or library account? Click to login
Spatial and Temporal Heterogeneity in Clonal Evolution of Nonsmall-cell Lung Cancer: Implications for Therapy Cover

Spatial and Temporal Heterogeneity in Clonal Evolution of Nonsmall-cell Lung Cancer: Implications for Therapy

Forum of Clinical Oncology
Volume 13 (2022): Issue 3 (December 2022)
By: A. Koulouris,  C. Tsagkaris and  G. Mountzios  
Open Access
|Oct 2023
Authors

Authors

A. Koulouris

andreas.koulouris@gmail.com

Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden
University of Crete, Faculty of Medicine, Heraklion, Greece

C. Tsagkaris

European Student Think Tank, Public Health and Policy Working Group, Amsterdam, Netherlands

G. Mountzios

Department of Medical Oncology, 251 General Airforce Hospital, Athens, Greece
DOI: https://doi.org/10.2478/fco-2023-0005 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 3 - 14
Submitted on: Jun 20, 2023
Accepted on: Jul 25, 2023
Published on: Oct 12, 2023
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Nonsmall-cell lung cancer,
NSCLC,
heterogeneity,
immunotherapy,
targeted treatment
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2023 A. Koulouris, C. Tsagkaris, G. Mountzios, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 13 (2022): Issue 3 (December 2022)
Previous article
Next article